Clinical Trials Arena on MSN
Pfizer reports positive phase II data for PF-07872412 in infants
After the fourth dose, the titers were approximately 15-fold higher with 25vPnC than PREVNAR 20.
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
May 20 (Reuters) - Pfizer said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune response than its current shot, including up to 15-fold higher antibody levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results